Detalhe da pesquisa
1.
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
Influenza Other Respir Viruses;
18(3): e13269, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494192
2.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis;
78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
3.
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
Vaccine;
41(37): 5424-5434, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479609
4.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics;
151(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026401
5.
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
JAMA Netw Open;
6(3): e232598, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920396
6.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
7.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis;
227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
8.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580430
9.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep;
71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264840
10.
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study.
BMJ;
379: e072141, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191948
11.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep;
71(29): 931-939, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862287
12.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239634
13.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep;
71(13): 495-502, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358170
14.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(7): 255-263, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176007
15.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep;
71(4): 139-145, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085224
16.
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021.
Am J Transplant;
22(1): 306-314, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967121
17.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep;
70(44): 1539-1544, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735425
18.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep;
70(44): 1553-1559, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735426
19.
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med;
385(15): 1355-1371, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496194
20.
A case of lymphangioleiomyomatosis originated in the pelvic cavity.
J Gynecol Oncol;
19(3): 195-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19471572